INTRODUCTION
The cytogenetic prenatal diagnosis includes fetal sex determination, which is always confirmed by the ultrasonographic scan as part of the routine pregnancy control. In those cases with a discrepancy between both results appeared, additional analysis have to be performed in order to find out the real fetal sex as well as to exclude a possible mistake or change between amniotic fluid samples. The molecular approach of fetal DNA analysis is useful in these cases.
The SRY gene has been proven to be determinant in the male sexual differentiation pathway during fetal life, initiating a genetic cascade leading to testicular development (1) . This gene is located on the short arm of chromosome Y, but might be transferred to the X chromosome by unequal interchange between short arms of the sex chromosomes during paternal meiosis (2) . This is the cause of the majority of the XX male cases.
We present a case in which a prenatal diagnosis of an XX male after a karyotype/phenotype discrepancy was performed using the molecular analysis of SRY and Amelogenin gene.
MATERIALS AND METHODS
Fetal blood and amniotic fluid samples from a pregnant woman at 20 gestation weeks were sent to our laboratory in order to clarify the discrepancy of fetal sex. Cytogenetic analysis in amniocytes had revealed a 46, XX karyotype, while ultrasonographic scan at 20 weeks of gestation had showed male external genitalia.
Genomic DNA for molecular studies was obtained from amniotic fluid and fetal blood. DNA from 3-ml of amniotic fluid was isolated using Chelex resin (Instagen Matrix, Biorad). Fetal blood DNA was isolated by two different methods, Chelex resin and DNA BOX 500 kit (Protrams). The oligonucleotids used and PCR conditions were those previously reported (http://www.gdb.org;) (3).
RESULTS AND DISCUSSION
The results of the molecular analysis of SRY gene detected the presence of this gene in all three samples (Fig. 1a) . The analysis of the Amelogenin gene showed a female pattern (Fig. 1b) corresponding to the absence of the Y chromosome.
The parents were informed of the XX male diagnosis and they decided to continue the pregnancy.
The prenatal karyotype/phenotype discrepancy occurs in approximately one out of 2500 analyzed gestations (4), leading usually to a high parental anxiety. The molecular approach of fetal DNA analysis is useful in most of these cases (5) .
In the present report, the molecular analysis confirmed the previous results of karyotype and ultrasound. The detection of the SRY gene justified the presence of male genitalia. The amplification of the Amelogenin gene according to a female pattern justified the absence of the Y chromosome and therefore the 46, XX karyotype. In addition, the analysis with both genes simultaneously allowed a rapid diagnosis of an XX male.
The incidence of 46, XX males is estimated in 1/20000 male neonates (6) . SRY sequences are present in at least 80% of these cases (7) . Some of the XX male, as well as other cases with sexual differentiation disorders, implies other genes, some of them are not known yet (8) . Nevertheless, the molecular analysis of fetal DNA using both genes (Amelogenin and SRY) is a rapid, simple and in many cases useful method to a definite prenatal diagnosis, which allows early parental counseling.
